Dana-Farber/Brigham and Women’s Cancer Center to launch nation’s first tissue-screening program for immunotherapies

cancer immunotherapies

Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) will become the first treatment center in the United States to routinely test patients’ tumor tissue to determine whether the cancer is likely to respond to immunotherapies. The testing, expected to begin in early 2018, will initially be offered to select patients in several DF/BWCC treatment centers, and the…

Memorial gift creates fellowship to celebrate patient’s love of learning and discovery

memorial giving

Maureen Twomey had a lifelong love of learning. She was an avid reader, and had earned degrees from both Tufts University and Harvard University. She also would complete the notoriously difficult crossword puzzle in The New York Times, and enjoyed going to museums. Throughout a difficult two-year battle with esophageal cancer, Maureen found that her…

10 Evidence-Based Cancer Prevention Tips

Cancer researchers continue to explore why cancer occurs in the body – and how to stop it before it shows up. Tools like genetic testing, which looks for alterations, or mutations, in a person’s genes, can help determine whether a person is more likely to develop certain kinds of cancer. But researchers have also identified…

Five Skin Cancer Myths Debunked

How much do you know about skin cancer? With an estimated one in five Americans developing skin cancer in their lifetime, this often-misunderstood disease is the most common form of cancer in the United States. We talked to Dr. Stephen F. Hodi, director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber/Brigham and…